Anti-Parkinson's Drugs Markets, 2022

Dublin, April 10, 2018 -- The "Anti-Parkinson's Drugs: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.

This research report categorizes the anti-Parkinson's drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson's medications.

Report Includes:

• An overview of the global market for anti-Parkinson's drugs and their future demand
• Analyses of global market trends, with data from 2013-2017, and projections of compound annual growth rates (CAGRs) through 2022
• Analyses of the major factors and technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson's disease
• Discussion of the major segments of the anti-Parkinson's drugs, i.e., dopaminergic drugs, dopamine agonists, enzyme inhibitors and other anti-Parkinson's medications
• Company profiles of the major players in the market, including AbbVie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis

Key Highlights:

• The global anti-Parkinson's drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1%, from 2017 to 2022.
• Asia Pacific anti-Parkinson's drugs market is expected to grow from $1.0 billion in 2017 to $1.4 billion in 2022 at a CAGR of 6.4% for the period 2017-2022.
• North American anti-Parkinson's drugs market is expected to grow from $1.3 billion in 2017 to $1.8 billion in 2022 at a CAGR of 7.0% for the period 2017-2022.

Key Topics Covered:

1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• Related Research Reports

2 Summary and Highlights

3 Anti-Parkinson's Drugs Market Characteristics

4 Anti-Parkinson's Drugs Market Size and Growth

• Historic Market Growth
• Drivers of the Market
• Restraints on the Market
• Forecast Market Growth
• Drivers of the Market
• Restraints on the Market

5 Anti-Parkinson's Drugs Market Trends and Strategies

• New Medication to Help the Body Absorb Parkinson's Disease Medication
• Free Water Biomarker to Track Changes in Brain
• 3D Printing Technology

6 PESTLE Analysis

• Political
• Government Financial Support
• Uncertain Political Policies
• Government Intervention
• Economic
• Wealth
• Globalization
• Emerging Markets
• Social
• Aging Global Population
• Health Consciousness and Awareness
• Traditional Medicine Continues to Pose Threat to Market
• Shortage of Skill
• Technological
• Technological Breakthroughs
• Wearable Technology and Hardware Advancements
• Internet Penetration and Mobile Applications
• Legal
• Stringent Regulations and Long Approval Procedures
• Tax Exemptions Initiatives and Subsidies
• Investment Regulations
• Environmental

7 Anti-Parkinson's Drugs Market Segmentation

• Global Anti-Parkinson's Drugs Market, by Segment
• Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
• Dopaminergics Market
• Market Characteristics
• Market Trends and Strategies
• Dopamine Agonists Market
• Market Characteristics
• Market Trends and Strategies
• Enzyme Inhibitors Market
• Market Characteristics
• Market Trends and Strategies
• Other Anti-Parkinson's Medications Market
• Market Characteristics

8 Anti-Parkinson's Drugs Market Regional and Country Analysis

• Global Anti-Parkinson's Drugs Market, by Region
• Global Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Region
• Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017
• Global Anti-Parkinson's Drugs Market, by Country
• Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Country
• Global Anti-Parkinson's Drugs Market Segmentation, 2017, by Country

9 Global Anti-Parkinson's Drugs Market Comparison with Macro Economic Factors

• Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure
• Per Capita Average Anti-Parkinson's Drugs Market Expenditure, by Country

10 Asia-Pacific Anti-Parkinson's Drugs Market

• Asia-Pacific Anti-Parkinson's Drugs Market Overview
• Region Information
• Market Information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Export and Import Duties on Anti-Parkinson Drugs
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• Asia-Pacific Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• Asia-Pacific Anti-Parkinson's Drugs Market Forecast Market
• Asia-Pacific Anti-Parkinson's Drugs Market, by Segment
• Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast CAGR, by Segment

11 Asia-Pacific Anti-Parkinson's Drugs Market: Country Analysis

• China Anti-Parkinson's Drugs Market Overview
• Country Information
• Market information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Export and Import Duties on Anti-Parkinson Drugs
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• China Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• China Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
• China Market Size, by Segment
• China Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
• India Anti-Parkinson's Drugs Market Overview
• Country Information
• Market Information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Import and Export Duties
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• India Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• India Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
• India Market Size, by Segment
• India Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
• Japan Anti-Parkinson's Drugs Market Overview
• Country Information
• Market Information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Import and Export Duties on Anti-Parkinson Drugs
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• Japan Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• Japan Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
• Japan Market Size, by Segment
• Japan Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
• Australia Anti-Parkinson's Drugs Market
• Australia Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• Australia Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
• Australia Market Size, by Segment
• Australia Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

12 Western Europe Anti-Parkinson's Drugs Market

• Western European Anti-Parkinson's Drugs Market Overview
• Region Information
• Market Information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• Western Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
• Western Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
• Western Europe Market Size, by Segment
• Western Europe Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

13 Western Europe Anti-Parkinson's Drugs Market: Country Analysis

• UK Anti-Parkinson's Drugs Market Overview
• Country Information
• Market information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Export and Import Duties on Anti-Parkinson Drugs
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• UK Anti-Parkinson's Drugs Historic Market, 2013-2017
• UK Anti-Parkinson's Drugs Forecast Market, 2017-2022
• UK Market Size, by Segment
• UK Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
• Germany Anti-Parkinson's Drugs Market
• Germany Anti-Parkinson's Drugs Historic Market, 2013-2017
• Germany Anti-Parkinson's Drugs Forecast Market, 2017-2022
• Germany Market Size, by Segment
• Germany Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
• France Anti-Parkinson's Drugs Market
• France Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• France Anti-Parkinson's Drugs Forecast Market, 2017-2022
• France Market Size, by Segment
• France Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
• Italy Anti-Parkinson's Drugs Market
• Italy Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• Italy Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
• Italy Market Size, by Segment
• Italy Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022,
• Spain Anti-Parkinson's Drugs Market
• Spain Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022
• Spain Market Size, by Segment
• Spain Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

14 Eastern Europe Anti-Parkinson's Drugs Market

• Eastern European Anti-Parkinson's Drugs Market Overview
• Region Information
• Market Information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Export and Import Duties On Anti-Parkinson Drugs
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• Eastern Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
• Eastern Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
• Eastern Europe Market Size, by Segment
• Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

15 Eastern Europe Anti-Parkinson's Drugs Market: Country Analysis

• Russia Anti-Parkinson's Drugs Market
• Russia Anti-Parkinson's Drugs Historic Market, 2013-2017
• Russia Anti-Parkinson's Drugs Forecast Market, 2017-2022
• Russia Market Size, by Segment
• Russia Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

16 North America Anti-Parkinson's Drugs Market

• North America Anti-Parkinson's Drugs Market Overview
• Region Information
• Market Information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• North America Anti-Parkinson's Drugs Historic Market, 2013-2017
• North America Anti-Parkinson's Drugs Forecast Market, 2017-2022
• North America Market Size, by Segment
• North America Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

17 North America Anti-Parkinson's Drugs Market: Country Analysis

• USA Anti-Parkinson's Drugs Market
• USA Anti-Parkinson's Drugs Market Historic Market, 2013-2017
• USA Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
• USA Market Size, by Segment
• USA Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

18 South America Anti-Parkinson's Drugs Market

• South America Anti-Parkinson's Drugs Market Overview
• Region Information
• Market Information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulatory Bodies
• Regulations
• Major Associations
• Taxes Levied
• Corporate Tax Structure
• Competitive Landscape
• South America Anti-Parkinson's Drugs Historic Market, 2013-2017
• South America Anti-Parkinson's Drugs Forecast Market, 2017-2022
• South America Market Size, by Segment
• South America Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

19 South America Anti-Parkinson's Drugs Market: Country Analysis

• Brazil Anti-Parkinson's Drugs Market
• Brazil Anti-Parkinson's Drugs Historic Market, 2013-2016
• Brazil Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
• Brazil Market Size, by Segment
• Brazil Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

20 Middle East Anti-Parkinson's Drugs Market

• Middle Anti-Parkinson's Drugs Market Overview
• Region Information
• Market information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Major Contracts/Research and Development Projects
• Regulations
• Regulatory Bodies
• Major Associations
• Competitive Landscape
• Middle East Anti-Parkinson's Drugs Historic Market, 2013-2017
• Middle East Anti-Parkinson's Drugs Forecast Market, 2017-2022
• Middle East Market Size, by Segment
• Middle East Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

21 Africa Anti-Parkinson's Drugs Market

• Africa Anti-Parkinson's Drugs Market Overview
• Region Information
• Market information
• Prevalence of Parkinson's Disease
• Government Initiatives
• Regulatory Bodies
• Major Associations
• Export and Import Duties on Anti-Parkinson Drugs
• Competitive Landscape
• Africa Anti-Parkinson's Drugs Historic Market, 2013-2017
• Africa Anti-Parkinson's Drugs Forecast Market, 2017-2022
• Africa Market Size, by Segment
• Africa Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

22 Anti-Parkinson's Drugs Market Customer Information

• Significant Impact of Parkinson's Disease on Quality of Life
• Knowledge Gaps among Parkinson's Patients and Caregivers
• Parkinson's Awareness in UK
• Knowledge on Parkinson's Disease among Patients and General Neurologists
• Power of Placebo

23 Anti-Parkinson's Drugs Market Competitive Landscape

• Company Profiles
• ABBVIE
• BOEHRINGER INGELHEIM
• F. HOFFMANN-LA ROCHE AG
• NOVARTIS AG
• UCB SA

24 Key Mergers and Acquisitions in the Anti-Parkinson's Drugs Market

• Teva Pharmaceutical Acquired Auspex Pharmaceuticals
• Mitsubishi Tanabe Acquired NeuroDerm
• Sunovion Pharmaceuticals Acquired Cynapsus Therapeutics
• Acorda Therapeutics Acquired Civitas Therapeutics
• Acorda Therapeutics Acquired Biotie Therapies

25 Appendix

• Definitions of the Industry
• Anti-Parkinson's Drugs
• Research Methodology

26 References

For more information about this report visit https://www.researchandmarkets.com/research/52xjjn/antiparkinsons?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Central Nervous System Drugs